AIDOT

About:

AIDOT develops medical software using AI. Their flagship product makes cervical cancer screening faster, easier and more accurate.

Website: http://www.aidot.ai

Top Investors: KOREA INVESTMENT & SECURITIES, Findvalue Asset Management

Description:

AIDot developed Cerviray A.I., an artificial intelligence-based diagnostic solution that combines traditional cervical enlargement photography and artificial intelligence to make cervical cancer screening faster and more accurate -- in fact, we’ve achieved 90% accuracy in a certified test report in 2019. This is in contrast to the 50% false-negative rate common for cervical cancer tests. AIDOT's solution is handheld and uses a mobile phone or tablet. It enables any relevant healthcare professional to detect cervical dysplasia and cancer with just one click and around ten seconds of AI analysis, compared to around one week for traditional tests.

Total Funding Amount:

$12.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Songpadong, Seoul-t'ukpyolsi, South Korea

Founded Date:

2014-06-12

Contact Email:

jman(AT)aidot.ai

Founders:

Michael Jeong, Sung Won Choi

Number of Employees:

11-50

Last Funding Date:

2021-08-21

IPO Status:

Private

© 2024 MyAiNote.com